Independent Director · Poseida Therapeutics, Inc. (PSTX)

Charles M. Baum director compensation at Poseida Therapeutics: $150K

Fiscal year 2023 director compensation for Charles M. Baum at Poseida Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 25, 2024 (DEF 14A). Open the filing on EDGAR.

Free

Get Charles M. Baum’s full pay file as a PDF — free

More than this page: up to 10 years of Charles’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Charles M. Baum and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Poseida Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Poseida Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2023$54,167$48,536$47,573$0$150,276

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Poseida Therapeutics, Inc. DEF 14A filed April 25, 2024, accession 0000950170-24-048291, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Poseida Therapeutics, Inc. filed document, accession 0000950170-24-048291. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2024.

Get the Poseida Therapeutics Board Governance Report

$150,276 Charles M. Baum, FY2023 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 25, 2024 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2023

Poseida Therapeutics pays directors a $40,000 cash retainer and $275,000 in Options/RSUs.

Committees

FY2023 · as the proxy prints them

Audit · Compensation · Science and Technology Committee

The rest of the Poseida Therapeutics board

FY2023 · as the company reported each
DirectorRoleFY2023 total
Cynthia CollinsIndependent Director$155,276
John P. SchmidIndependent Director$175,109
Kristin YaremaDirector—
Luke CorningIndependent Director$140,109
Marcea B. LloydIndependent Director$149,109
Mark J. GergenChair of the Board—
Rafael G. AmadoIndependent Director$248,172

The full Poseida Therapeutics compensation record

free company brief

This page is one director within Poseida Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order PSTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report